Targeting Cannabinoid Signaling in the Immune System: “High”-ly Exciting Questions, Possibilities, and Challenges
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting Cannabinoid Signaling in the Immune System: “High”-ly Exciting Questions, Possibilities, and Challenges
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 8, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2017-11-10
DOI
10.3389/fimmu.2017.01487
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Bidirectional allosteric interactions between cannabinoid receptor 1 (CB 1 ) and dopamine receptor 2 long (D 2L ) heterotetramers
- (2017) Amina M. Bagher et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Target regulation of PI3K/Akt/mTOR pathway by cannabidiol in treatment of experimental multiple sclerosis
- (2017) Sabrina Giacoppo et al. FITOTERAPIA
- Janus kinase inhibition for immunosuppression in solid organ transplantation: Is there a role in complex immunologic challenges?
- (2017) Cody A. Moore et al. HUMAN IMMUNOLOGY
- (−)-β-Caryophyllene, a CB2 Receptor-Selective Phytocannabinoid, Suppresses Motor Paralysis and Neuroinflammation in a Murine Model of Multiple Sclerosis
- (2017) Thaís Alberti et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Anticancer effects of phytocannabinoids used with chemotherapy in leukaemia cells can be improved by altering the sequence of their administration
- (2017) Katherine A. Scott et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Δ9-Tetrahydrocannabinol Suppresses Secretion of IFNα by Plasmacytoid Dendritic Cells From Healthy and HIV-Infected Individuals
- (2017) Joseph E. Henriquez et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Amidoalkylindoles as Potent and Selective Cannabinoid Type 2 Receptor Agonists with in Vivo Efficacy in a Mouse Model of Multiple Sclerosis
- (2017) Ying Shi et al. JOURNAL OF MEDICINAL CHEMISTRY
- Potent immunomodulatory activity of a highly selective cannabinoid CB2 agonist on immune cells from healthy subjects and patients with multiple sclerosis
- (2017) Pasquale Annunziata et al. JOURNAL OF NEUROIMMUNOLOGY
- Cannabis: A Treasure Trove or Pandora's Box?
- (2017) Katalin Solymosi et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- A chronic low dose of Δ9-tetrahydrocannabinol (THC) restores cognitive function in old mice
- (2017) Andras Bilkei-Gorzo et al. NATURE MEDICINE
- Toll-like receptor signalling as a cannabinoid target in Multiple Sclerosis
- (2017) John-Mark K. Fitzpatrick et al. NEUROPHARMACOLOGY
- Characterization of structurally novel G protein biased CB 1 agonists: Implications for drug development
- (2017) Benjamin M. Ford et al. PHARMACOLOGICAL RESEARCH
- Chemical probes to potently and selectively inhibit endocannabinoid cellular reuptake
- (2017) Andrea Chicca et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Endocannabinoid system acts as a regulator of immune homeostasis in the gut
- (2017) Nandini Acharya et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Activity-based protein profiling reveals off-target proteins of the FAAH inhibitor BIA 10-2474
- (2017) Annelot C. M. van Esbroeck et al. SCIENCE
- Tumor-promoting effects of cannabinoid receptor type 1 in human melanoma cells
- (2017) Sara Carpi et al. TOXICOLOGY IN VITRO
- Treg therapy in transplantation: a general overview
- (2017) Marco Romano et al. TRANSPLANT INTERNATIONAL
- Cannabinoid CB2 receptor ligand profiling reveals biased signalling and off-target activity
- (2017) Marjolein Soethoudt et al. Nature Communications
- Cannabinoids therapeutic use: what is our current understanding following the introduction of THC, THC:CBD oromucosal spray and others?
- (2017) Mauro Maccarrone et al. Expert Review of Clinical Pharmacology
- Modulation of Human Peripheral Blood Mononuclear Cell Signaling by Medicinal Cannabinoids
- (2017) Wesley K. Utomo et al. Frontiers in Molecular Neuroscience
- Metabolism of the Endocannabinoid Anandamide: Open Questions after 25 Years
- (2017) Mauro Maccarrone Frontiers in Molecular Neuroscience
- Inhibition of Toll-Like Receptor Signaling as a Promising Therapy for Inflammatory Diseases: A Journey from Molecular to Nano Therapeutics
- (2017) Wei Gao et al. Frontiers in Physiology
- Targeting Cutaneous Cannabinoid Signaling in Inflammation - A “High”-way to Heal?
- (2017) Attila Oláh et al. EBioMedicine
- Effects on Spasticity and Neuropathic Pain of an Oral Formulation of Δ9-tetrahydrocannabinol in Patients WithProgressive Multiple Sclerosis
- (2017) Guido van Amerongen et al. CLINICAL THERAPEUTICS
- Transient Cannabinoid Receptor 2 Blockade during Immunization Heightens Intensity and Breadth of Antigen-specific Antibody Responses in Young and Aged mice
- (2017) Emmanuel Dotsey et al. Scientific Reports
- Cannabinoids and autoimmune diseases: A systematic review
- (2016) Valeria Katchan et al. AUTOIMMUNITY REVIEWS
- Biased signaling of lipids and allosteric actions of synthetic molecules for GPR119
- (2016) Helle A. Hassing et al. BIOCHEMICAL PHARMACOLOGY
- An update on PPAR activation by cannabinoids
- (2016) Saoirse Elizabeth O'Sullivan BRITISH JOURNAL OF PHARMACOLOGY
- What is the evidence for the role of TRP channels in inflammatory and immune cells?
- (2016) A Parenti et al. BRITISH JOURNAL OF PHARMACOLOGY
- Novel psychoactive substances: What educators need to know
- (2016) ZR Patterson et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Medical cannabis: Another piece in the mosaic of autoimmunity?
- (2016) D Katz et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Cannabinoids and Cytochrome P450 Interactions
- (2016) Ondřej Zendulka et al. CURRENT DRUG METABOLISM
- The Emerging Role of the Cannabinoid Receptor Family in Peripheral and Neuro-immune Interactions
- (2016) Orla Haugh et al. CURRENT DRUG TARGETS
- CB2-63 polymorphism and immune-mediated diseases associated with HCV chronic infection
- (2016) Nicola Coppola et al. DIGESTIVE AND LIVER DISEASE
- Cannabinoid pharmacology in cancer research: A new hope for cancer patients?
- (2016) Farideh A. Javid et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Inhibition of fatty acid amide hydrolase exerts cutaneous anti-inflammatory effects bothin vitroandin vivo
- (2016) Attila Oláh et al. EXPERIMENTAL DERMATOLOGY
- Phyto-, endo- and synthetic cannabinoids: promising chemotherapeutic agents in the treatment of breast and prostate carcinomas
- (2016) A. I. Fraguas-Sánchez et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Antitumorigenic targets of cannabinoids – current status and implications
- (2016) Robert Ramer et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- The effect of cannabinoids on the stretch reflex in multiple sclerosis spasticity
- (2016) Lucio Marinelli et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Cannabidiol: a potential treatment for post Ebola syndrome?
- (2016) Sandra E. Reznik et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Simultaneous Activation of Induced Heterodimerization between CXCR4 Chemokine Receptor and Cannabinoid Receptor 2 (CB2) Reveals a Mechanism for Regulation of Tumor Progression
- (2016) Christopher J. Coke et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Cannabinoid Receptor 2 Modulates Susceptibility to Experimental Cerebral Malaria through a CCL17-dependent Mechanism
- (2016) Judith Alferink et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Chromenopyrazole, a Versatile Cannabinoid Scaffold with in Vivo Activity in a Model of Multiple Sclerosis
- (2016) Paula Morales et al. JOURNAL OF MEDICINAL CHEMISTRY
- Pathways and gene networks mediating the regulatory effects of cannabidiol, a nonpsychoactive cannabinoid, in autoimmune T cells
- (2016) Ewa Kozela et al. Journal of Neuroinflammation
- Efficacy and safety of cannabinoid oromucosal spray for multiple sclerosis spasticity
- (2016) F Patti et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- The use of medical-grade cannabis in patients non-responders to Nabiximols
- (2016) Francesco Saccà et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Cortical and spinal excitability in patients with multiple sclerosis and spasticity after oromucosal cannabinoid spray
- (2016) Giovanna Squintani et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Ligands for cannabinoid receptors, promising anticancer agents
- (2016) Marjan Nikan et al. LIFE SCIENCES
- Interaction between Cannabinoid System and Toll-Like Receptors Controls Inflammation
- (2016) Kathleen L. McCoy MEDIATORS OF INFLAMMATION
- Cannabidiol Limits T Cell-Mediated Chronic Autoimmune Myocarditis: Implications to Autoimmune Disorders and Organ Transplantation
- (2016) Wen-Shin Lee et al. MOLECULAR MEDICINE
- The impact of drugs for multiple sclerosis on sleep
- (2016) Giuseppe Lanza et al. Multiple Sclerosis Journal
- A cannabinoid link between mitochondria and memory
- (2016) Etienne Hebert-Chatelain et al. NATURE
- Bial incident raises FAAH suspicions
- (2016) Eva von Schaper NATURE BIOTECHNOLOGY
- Microglia activation states and cannabinoid system: Therapeutic implications
- (2016) M. Mecha et al. PHARMACOLOGY & THERAPEUTICS
- From Phytocannabinoids to Cannabinoid Receptors and Endocannabinoids: Pleiotropic Physiological and Pathological Roles Through Complex Pharmacology
- (2016) Alessia Ligresti et al. PHYSIOLOGICAL REVIEWS
- The use of cannabinoids as anticancer agents
- (2016) Guillermo Velasco et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Tolerogenic dendritic cell therapy in organ transplantation
- (2016) Aurélie Moreau et al. TRANSPLANT INTERNATIONAL
- Beyond Cannabis: Plants and the Endocannabinoid System
- (2016) Ethan B. Russo TRENDS IN PHARMACOLOGICAL SCIENCES
- Overexpression of cannabinoid receptor 1 promotes renal cell carcinoma progression
- (2016) Jianfeng Wang et al. TUMOR BIOLOGY
- Endocannabinoid system as a regulator of tumor cell malignancy – biological pathways and clinical significance
- (2016) Maria Pyszniak et al. OncoTargets and Therapy
- The Use of Medical Marijuana in Cancer
- (2016) Shauna M. Birdsall et al. Current Oncology Reports
- CB2 cannabinoid receptor activation promotes colon cancer progression via AKT/GSK3β signaling pathway
- (2016) Esther Martínez-Martínez et al. Oncotarget
- The impact of drugs for multiple sclerosis on sleep
- (2016) Giuseppe Lanza et al. Multiple Sclerosis Journal
- Preclinical and Clinical Assessment of Cannabinoids as Anti-Cancer Agents
- (2016) Daniel A. Ladin et al. Frontiers in Pharmacology
- CB2 and GPR55 Receptors as Therapeutic Targets for Systemic Immune Dysregulation
- (2016) Juan Zhou et al. Frontiers in Pharmacology
- The Crosstalk between Myeloid Derived Suppressor Cells and Immune Cells: To Establish Immune Tolerance in Transplantation
- (2016) Chao Zhang et al. Journal of Immunology Research
- Cannabidiol for the Prevention of Graft-versus-Host-Disease after Allogeneic Hematopoietic Cell Transplantation: Results of a Phase II Study
- (2015) Moshe Yeshurun et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Endocannabinoid signalling in innate and adaptive immunity
- (2015) Valerio Chiurchiù et al. IMMUNOLOGY
- The endocannabinoid system and its therapeutic implications in rheumatoid arthritis
- (2015) Huan Gui et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Δ9 -Tetrahydrocannabinol attenuates allogeneic host-versus-graft response and delays skin graft rejection through activation of cannabinoid receptor 1 and induction of myeloid-derived suppressor cells
- (2015) Jessica M. Sido et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Effects of cannabinoids and their receptors on viral infections
- (2015) Alireza Tahamtan et al. JOURNAL OF MEDICAL VIROLOGY
- The Antitumor Activity of Plant-Derived Non-Psychoactive Cannabinoids
- (2015) Sean D. McAllister et al. Journal of Neuroimmune Pharmacology
- Cannabinoid Signaling and Neuroinflammatory Diseases: A Melting pot for the Regulation of Brain Immune Responses
- (2015) Valerio Chiurchiù et al. Journal of Neuroimmune Pharmacology
- Epigenetic Regulation of Immunological Alterations Following Prenatal Exposure to Marijuana Cannabinoids and its Long Term Consequences in Offspring
- (2015) Elizabeth E. Zumbrun et al. Journal of Neuroimmune Pharmacology
- Exposure of Adolescent Mice to Delta-9-Tetrahydrocannabinol Induces Long-Lasting Modulation of Pro- and Anti-Inflammatory Cytokines in Hypothalamus and Hippocampus Similar to that Observed for Peripheral Macrophages
- (2015) Sarah Moretti et al. Journal of Neuroimmune Pharmacology
- Modulation of HIVGP120 Antigen-Specific Immune Responses In Vivo by Δ9-Tetrahydrocannabinol
- (2015) Weimin Chen et al. Journal of Neuroimmune Pharmacology
- Turning Over a New Leaf: Cannabinoid and Endocannabinoid Modulation of Immune Function
- (2015) Guy A. Cabral et al. Journal of Neuroimmune Pharmacology
- Δ9-Tetrahydrocannabinol (Δ9-THC) Promotes Neuroimmune-Modulatory MicroRNA Profile in Striatum of Simian Immunodeficiency Virus (SIV)-Infected Macaques
- (2015) Liz Simon et al. Journal of Neuroimmune Pharmacology
- Danger- and pathogen-associated molecular patterns recognition by pattern-recognition receptors and ion channels of the transient receptor potential family triggers the inflammasome activation in immune cells and sensory neurons
- (2015) Giorgio Santoni et al. Journal of Neuroinflammation
- The cannabinoid receptor 2 is involved in acute rejection of cardiac allografts
- (2015) Andrea M. Kemter et al. LIFE SCIENCES
- Cannabidiol increases survival and promotes rescue of cognitive function in a murine model of cerebral malaria
- (2015) A.C. Campos et al. NEUROSCIENCE
- The Endocannabinoid System and its Modulation by Phytocannabinoids
- (2015) Vincenzo Di Marzo et al. Neurotherapeutics
- Polypharmacology Shakes Hands with Complex Aetiopathology
- (2015) James S. Brodie et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Endocannabinoid signaling at the periphery: 50 years after THC
- (2015) Mauro Maccarrone et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Alcohol and Cannabinoids Differentially Affect HIV Infection and Function of Human Monocyte-Derived Dendritic Cells (MDDC)
- (2015) Marisela Agudelo et al. Frontiers in Microbiology
- Balancing Innate Immunity and Inflammatory State via Modulation of Neutrophil Function: A Novel Strategy to Fight Sepsis
- (2015) Haoshu Fang et al. Journal of Immunology Research
- TRP Channel Cannabinoid Receptors in Skin Sensation, Homeostasis, and Inflammation
- (2014) Michael J. Caterina ACS Chemical Neuroscience
- Heteromerization of GPR55 and cannabinoid CB2receptors modulates signalling
- (2014) N A Balenga et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cannabis for Inflammatory Bowel Disease
- (2014) Timna Naftali et al. DIGESTIVE DISEASES
- Cnr2 Deficiency Confers Resistance to Inflammation-Induced Preterm Birth in Mice
- (2014) Xiaofei Sun et al. ENDOCRINOLOGY
- Role of Endocannabinoid Activation of Peripheral CB1 Receptors in the Regulation of Autoimmune Disease
- (2014) Jessica Margaret Sido et al. INTERNATIONAL REVIEWS OF IMMUNOLOGY
- Cannabidiol exerts sebostatic and antiinflammatory effects on human sebocytes
- (2014) Attila Oláh et al. JOURNAL OF CLINICAL INVESTIGATION
- Δ9 -Tetrahydrocannabinol-induced anti-inflammatory responses in adolescent mice switch to proinflammatory in adulthood
- (2014) Sarah Moretti et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Neuroprotection in Experimental Autoimmune Encephalomyelitis and Progressive Multiple Sclerosis by Cannabis-Based Cannabinoids
- (2014) Gareth Pryce et al. Journal of Neuroimmune Pharmacology
- Chronic Administration of Δ9-Tetrahydrocannabinol Induces Intestinal Anti-Inflammatory MicroRNA Expression during Acute Simian Immunodeficiency Virus Infection of Rhesus Macaques
- (2014) Lawrance C. Chandra et al. JOURNAL OF VIROLOGY
- Experimental Cannabinoid 2 Receptor-Mediated Immune Modulation in Sepsis
- (2014) J. Sardinha et al. MEDIATORS OF INFLAMMATION
- Cell-specific STORM super-resolution imaging reveals nanoscale organization of cannabinoid signaling
- (2014) Barna Dudok et al. NATURE NEUROSCIENCE
- A Cannabigerol Derivative Suppresses Immune Responses and Protects Mice from Experimental Autoimmune Encephalomyelitis
- (2014) Francisco J. Carrillo-Salinas et al. PLoS One
- Inhibition of Fatty Acid Binding Proteins Elevates Brain Anandamide Levels and Produces Analgesia
- (2014) Martin Kaczocha et al. PLoS One
- Effect of Delta-9-Tetrahydrocannabinol on Mouse Resistance to Systemic Candida albicans Infection
- (2014) Gideon W. Blumstein et al. PLoS One
- Cannabis use by individuals with multiple sclerosis: effects on specific immune parameters
- (2014) Michelle Sexton et al. INFLAMMOPHARMACOLOGY
- Cannabinoid CB2 receptor gene (CNR2) polymorphism is associated with chronic childhood immune thrombocytopenia in Egypt
- (2013) Heba Mahmoud Gouda et al. BLOOD COAGULATION & FIBRINOLYSIS
- Selective CB2 receptor activation ameliorates EAE by reducing Th17 differentiation and immune cell accumulation in the CNS
- (2013) Weimin Kong et al. CELLULAR IMMUNOLOGY
- Association Between a Polymorphism in Cannabinoid Receptor 2 and Severe Necroinflammation in Patients With Chronic Hepatitis C
- (2013) Nicola Coppola et al. Clinical Gastroenterology and Hepatology
- Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: A role for A2A receptors
- (2013) M. Mecha et al. NEUROBIOLOGY OF DISEASE
- Therapeutic potential of a novel cannabinoid agent CB52 in the mouse model of experimental autoimmune encephalomyelitis
- (2013) R. Ribeiro et al. NEUROSCIENCE
- Clinical implications for cannabinoid use in the rheumatic diseases: Potential for help or harm?
- (2012) Mary-Ann Fitzcharles et al. ARTHRITIS AND RHEUMATISM
- Cannabidiol, a non-psychotropic plant-derived cannabinoid, decreases inflammation in a murine model of acute lung injury: Role for the adenosine A2A receptor
- (2012) Alison Ribeiro et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Cannabidiol reduces host immune response and prevents cognitive impairments in Wistar rats submitted to pneumococcal meningitis
- (2012) Tatiana Barichello et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Evidence for Bidirectional Endocannabinoid Transport across Cell Membranes
- (2012) Andrea Chicca et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Activation of Cannabinoid Receptor 2 Attenuates Leukocyte-Endothelial Cell Interactions and Blood-Brain Barrier Dysfunction under Inflammatory Conditions
- (2012) S. H. Ramirez et al. JOURNAL OF NEUROSCIENCE
- Mitochondrial CB1 receptors regulate neuronal energy metabolism
- (2012) Giovanni Bénard et al. NATURE NEUROSCIENCE
- The Cannabinoid Receptor type 2 Q63R variant increases the risk of celiac disease: Implication for a novel molecular biomarker and future therapeutic intervention
- (2012) Francesca Rossi et al. PHARMACOLOGICAL RESEARCH
- Receptor Heteromerization Expands the Repertoire of Cannabinoid Signaling in Rodent Neurons
- (2012) Raphael Rozenfeld et al. PLoS One
- Δ9-Tetrahydrocannabinol Impairs the Inflammatory Response to Influenza Infection: Role of Antigen-Presenting Cells and the Cannabinoid Receptors 1 and 2
- (2012) Peer W. F. Karmaus et al. TOXICOLOGICAL SCIENCES
- Differential migratory properties of monocytes isolated from human subjects naïve and non-naïve to Cannabis
- (2012) Michelle Sexton et al. INFLAMMOPHARMACOLOGY
- The endocannabinoid anandamide downregulates IL-23 and IL-12 subunits in a viral model of multiple sclerosis: Evidence for a cross-talk between IL-12p70/IL-23 axis and IL-10 in microglial cells
- (2011) Fernando Correa et al. BRAIN BEHAVIOR AND IMMUNITY
- Administration of 2-arachidonoylglycerol ameliorates both acute and chronic experimental autoimmune encephalomyelitis
- (2011) Athanasios Lourbopoulos et al. BRAIN RESEARCH
- Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects
- (2011) Ethan B Russo BRITISH JOURNAL OF PHARMACOLOGY
- Heteromultimerization of Cannabinoid CB1Receptor and Orexin OX1Receptor Generates a Unique Complex in Which Both Protomers Are Regulated by Orexin A
- (2011) Richard J. Ward et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Adenosine A2A receptor activation stimulates collagen production in sclerodermic dermal fibroblasts either directly and through a cross-talk with the cannabinoid system
- (2011) Pietro Enea Lazzerini et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Cannabinoid Neuroimmune Modulation of SIV Disease
- (2011) Patricia E. Molina et al. Journal of Neuroimmune Pharmacology
- Targeting Cannabinoid Receptors as a Novel Approach in the Treatment of Graft-versus-Host Disease: Evidence from an Experimental Murine Model
- (2011) R. Pandey et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Targeting CB2 receptor as a neuroinflammatory modulator in experimental autoimmune encephalomyelitis
- (2011) Zhi-Yin Lou et al. MOLECULAR IMMUNOLOGY
- Cannabinoid Administration Attenuates the Progression of Simian Immunodeficiency Virus
- (2010) Patricia E. Molina et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Phytocannabinoids beyond the Cannabis plant - do they exist?
- (2010) J������rg Gertsch et al. BRITISH JOURNAL OF PHARMACOLOGY
- PTPN22 gene polymorphisms in autoimmune diseases with special reference to systemic lupus erythematosus disease susceptibility
- (2010) V Pradhan et al. Journal of Postgraduate Medicine
- Rimonabant for prevention of cardiovascular events (CRESCENDO): a randomised, multicentre, placebo-controlled trial
- (2010) Eric J Topol et al. LANCET
- Early onset of aging-like changes is restricted to cognitive abilities and skin structure in Cnr1−/− mice
- (2010) Andras Bilkei-Gorzo et al. NEUROBIOLOGY OF AGING
- International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2
- (2010) R. G. Pertwee et al. PHARMACOLOGICAL REVIEWS
- Do cannabinoids have a therapeutic role in transplantation?
- (2010) Mitzi Nagarkatti et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Evidence that the plant cannabinoid cannabigerol is a highly potent α2-adrenoceptor agonist and moderately potent 5HT1A receptor antagonist
- (2009) MG Cascio et al. BRITISH JOURNAL OF PHARMACOLOGY
- Anandamide enhances IL-10 production in activated microglia by targeting CB2receptors: Roles of ERK1/2, JNK, and NF-κB
- (2009) Fernando Correa et al. GLIA
- Cannabinoid activation of peroxisome proliferator-activated receptors: Potential for modulation of inflammatory disease
- (2009) S.E. O'Sullivan et al. IMMUNOBIOLOGY
- The Cannabinoid Receptor 2 Is Critical for the Host Response to Sepsis
- (2009) J. Tschop et al. JOURNAL OF IMMUNOLOGY
- Ulcerative Colitis Induces Changes on the Expression of the Endocannabinoid System in the Human Colonic Tissue
- (2009) Lucia Marquéz et al. PLoS One
- Receptors for acylethanolamides—GPR55 and GPR119
- (2009) Grzegorz Godlewski et al. PROSTAGLANDINS & OTHER LIPID MEDIATORS
- The endocannabinoid system of the skin in health and disease: novel perspectives and therapeutic opportunities
- (2009) Tamás Bíró et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Antibacterial Cannabinoids fromCannabis sativa: A Structure−Activity Study
- (2008) Giovanni Appendino et al. JOURNAL OF NATURAL PRODUCTS
- CB1 and CB2 Cannabinoid Receptors Mediate Different Aspects of Delta-9-Tetrahydrocannabinol (THC)-Induced T Helper Cell Shift Following Immune Activation by Legionella Pneumophila Infection
- (2008) Catherine A. Newton et al. Journal of Neuroimmune Pharmacology
- Beta-caryophyllene is a dietary cannabinoid
- (2008) Jürg Gertsch et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The diverse CB1and CB2receptor pharmacology of three plant cannabinoids: Δ9-tetrahydrocannabinol, cannabidiol and Δ9-tetrahydrocannabivarin
- (2007) R G Pertwee BRITISH JOURNAL OF PHARMACOLOGY
- Cannabinoid CB2receptors in the gastrointestinal tract: a regulatory system in states of inflammation
- (2007) K L Wright et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cannabinoid pharmacology: the first 66 years
- (2006) Roger G Pertwee BRITISH JOURNAL OF PHARMACOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started